Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 71

1.

Novel prognostic index based on hemoglobin level and platelet count for diffuse large B-cell lymphoma, not otherwise specified in the R-CHOP era.

Nakayama S, Matsuda M, Adachi T, Sueda S, Ohashi Y, Awaji S, Hashimoto S, Matsumura I.

Platelets. 2019;30(5):637-645. doi: 10.1080/09537104.2018.1499889. Epub 2018 Jul 26.

PMID:
30047815
2.

Five-day regimen of azacitidine for lower-risk myelodysplastic syndromes (refractory anemia or refractory anemia with ringed sideroblasts): A prospective single-arm phase 2 trial.

Morita Y, Maeda Y, Yamaguchi T, Urase F, Kawata S, Hanamoto H, Tsubaki K, Ishikawa J, Shibayama H, Matsumura I, Matsuda M.

Cancer Sci. 2018 Oct;109(10):3209-3215. doi: 10.1111/cas.13739. Epub 2018 Aug 26.

3.

Tumor necrosis factor- and interleukin-6-producing high-grade B-cell lymphoma, not otherwise specified in the pleura.

Nakayama S, Matsuda M, Adachi T, Sueda S, Ueda K, Kawahara K, Ohashi Y, Awaji S, Hashimoto S, Matsumura I.

Leuk Res Rep. 2018 Jun 28;10:1-3. doi: 10.1016/j.lrr.2018.06.001. eCollection 2018.

4.

Cytotoxic T-lymphocyte-associated antigen 4-positive aggressive adult T cell leukemia/lymphoma.

Sueda S, Nakayama S, Adachi T, Ohashi Y, Awaji S, Hashimoto S, Matsumura I, Matsuda M.

Ann Hematol. 2019 Jan;98(1):235-236. doi: 10.1007/s00277-018-3426-2. Epub 2018 Jul 6. No abstract available.

PMID:
29978285
5.

25-Hydroxyvitamin D3-1╬▒-hydroxylase- and multiple cytokine-producing diffuse large B-cell lymphoma.

Nakayama S, Matsuda M.

Blood. 2018 May 17;131(20):2271. doi: 10.1182/blood-2018-02-832568. No abstract available.

6.

Adult T cell leukemia/lymphoma with different pathological features in each tumor site.

Nakayama S, Matsuda M, Adachi T, Sueda S, Ohashi Y, Awaji S, Hashimoto S, Matsumura I.

Ann Hematol. 2018 Jun;97(6):1095-1096. doi: 10.1007/s00277-018-3272-2. Epub 2018 Feb 9. No abstract available.

PMID:
29427186
7.

Pomalidomide with or without dexamethasone for relapsed/refractory multiple myeloma in Japan: a retrospective analysis by the Kansai Myeloma Forum.

Matsumura-Kimoto Y, Kuroda J, Kaneko H, Kamitsuji Y, Fuchida SI, Nakaya A, Shibayama H, Uoshima N, Yokota I, Uchiyama H, Yagi H, Kosugi S, Matsui T, Ishikawa J, Matsuda M, Ohta K, Iida M, Tanaka H, Kobayashi M, Wada K, Shimazaki C, Nomura S, Imada K, Hino M, Matsumura I, Kanakura Y, Takaori-Kondo A; Kansai Myeloma Forum Investigators.

Int J Hematol. 2018 May;107(5):541-550. doi: 10.1007/s12185-018-2416-4. Epub 2018 Jan 29.

PMID:
29380179
8.

Superficial epidermolytic ichthyosis concomitant with atopic dermatitis.

Shimada H, Takeo N, Saito-Shono T, Ishikawa K, Sakai T, Goto M, Hatano Y, Fujiwara S, Matsuda M, Hamada T, Nakama T, Hashimoto T, Kono M, Akiyama M, Kitajima Y.

Eur J Dermatol. 2018 Feb 1;28(1):94-96. doi: 10.1684/ejd.2017.3158. No abstract available.

PMID:
29171394
9.

A Case of Hailey-Hailey Disease with a Novel Nonsense Mutation in the ATP2C1 Gene.

Yasuda H, Kanazawa N, Matsuda M, Hamada T, Furumura M, Hashimoto T, Nakama T, Furukawa F.

Ann Dermatol. 2017 Oct;29(5):642-644. doi: 10.5021/ad.2017.29.5.642. Epub 2017 Aug 25. No abstract available.

10.

Primary cutaneous plasmacytoma.

Matsuda M, Sueda S, Taniguchi T.

Int J Hematol. 2017 May;105(5):545-546. doi: 10.1007/s12185-017-2203-7. Epub 2017 Feb 28. No abstract available.

PMID:
28247190
11.

Prevalence of filaggrin gene mutations in patients with atopic dermatitis and ichthyosis vulgaris in Kyushu area of Japan and South Korea.

Teye K, Numata S, Krol RP, Ishii N, Matsuda M, Lee JB, Hamada T, Hashimoto T.

J Dermatol Sci. 2017 May;86(2):174-177. doi: 10.1016/j.jdermsci.2017.01.009. Epub 2017 Jan 22. No abstract available.

PMID:
28143684
12.

A compound synonymous mutation c.474G>A with p.Arg578X mutation in SPINK5 causes splicing disorder and mild phenotype in Netherton syndrome.

Numata S, Teye K, Krol RP, Okamatsu Y, Hashikawa K, Matsuda M, Fortugno P, Di Zenzo G, Castiglia D, Zambruno G, Hamada T, Hashimoto T.

Exp Dermatol. 2016 Jul;25(7):568-70. doi: 10.1111/exd.13011. Epub 2016 May 20. No abstract available.

PMID:
26997095
13.

Functional study of TGM1 missense mutations in autosomal recessive congenital ichthyosis.

Numata S, Teye K, Karashima T, Matsuda M, Hamada T, Hashimoto T.

Exp Dermatol. 2016 Aug;25(8):657-9. doi: 10.1111/exd.13000. Epub 2016 Jun 15. No abstract available.

PMID:
26990434
14.

Anti-early endosome antigen 1 autoantibodies were detected in a pemphigus-like patient but not in the majority of pemphigus diseases.

Nishikawa R, Takahashi H, Matsuda M, Imaoka K, Ogawa M, Teye K, Tsuchisaka A, Koga H, Komorowski L, Probst C, Hachiya T, Fritzler MJ, Ishii N, Ohata C, Furumura M, Krol RP, Muro Y, Morita E, Hashimoto T.

Exp Dermatol. 2016 May;25(5):368-74. doi: 10.1111/exd.12981.

PMID:
26909655
15.

A founder deletion of corneodesmosin gene is prevalent in Japanese patients with peeling skin disease: Identification of 2 new cases.

Teye K, Suga Y, Numata S, Soejima M, Ishii N, Krol RP, Ohata C, Matsuda M, Honma M, Ishida-Yamamoto A, Hamada T, Koda Y, Hashimoto T.

J Dermatol Sci. 2016 May;82(2):134-7. doi: 10.1016/j.jdermsci.2016.01.012. Epub 2016 Jan 29. No abstract available.

PMID:
26867961
16.

A three-dimensional in vitro culture model of Hailey-Hailey disease.

Matsuda M, Hamada T, Numata S, Teye K, Ishii N, Ohata C, Furumura M, Nakama T, Hashimoto T.

Exp Dermatol. 2015 Oct;24(10):788-9. doi: 10.1111/exd.12777. Epub 2015 Aug 18. No abstract available.

PMID:
26121994
17.

Loss of heterozygosity in a case of glomuvenous malformations.

Ohata C, Matsuda M, Hamada T, Shintani T, Muto I, Nagata H, Furumura M, Nakama T.

J Dermatol. 2015 Jun;42(6):646-7. doi: 10.1111/1346-8138.12849. Epub 2015 Mar 21. No abstract available.

PMID:
25809388
18.

Mutation study for 9 genes in 23 unrelated patients with autosomal recessive congenital ichthyosis in Japan and Malaysia.

Numata S, Teye K, Krol RP, Karashima T, Fukuda S, Matsuda M, Ishii N, Furumura M, Ohata C, Saminathan SD, Ariffin R, Pramono ZA, Leong KF, Hamada T, Hashimoto T.

J Dermatol Sci. 2015 Apr;78(1):82-5. doi: 10.1016/j.jdermsci.2015.02.006. Epub 2015 Feb 19. No abstract available. Erratum in: J Dermatol Sci. 2015 Aug;79(2):179-80.

PMID:
25766764
19.

Synthetic lateral inhibition governs cell-type bifurcation with robust ratios.

Matsuda M, Koga M, Woltjen K, Nishida E, Ebisuya M.

Nat Commun. 2015 Feb 5;6:6195. doi: 10.1038/ncomms7195.

PMID:
25652697
20.

Impact of early use of lenalidomide and low-dose dexamethasone on clinical outcomes in patients with relapsed/refractory multiple myeloma.

Kobayashi T, Kuroda J, Fuchida S, Kaneko H, Yagi H, Shibayama H, Tanaka H, Kosugi S, Uoshima N, Kobayashi M, Adachi Y, Ohta K, Ishii K, Uchiyama H, Matsuda M, Nakatani E, Tsudo M, Shimazaki C, Takaori-Kondo A, Nomura S, Matsumura I, Taniwaki M, Kanakura Y; KMF investigators.

Int J Hematol. 2015 Jan;101(1):37-45. doi: 10.1007/s12185-014-1696-6. Epub 2014 Nov 11.

PMID:
25385278

Supplemental Content

Loading ...
Support Center